Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$696M |
| 2 |
AABA
Altaba Inc
AABA
|
+$632M |
| 3 |
AT&T
T
|
+$433M |
| 4 |
Goldman Sachs
GS
|
+$392M |
| 5 |
Walt Disney
DIS
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$938M |
| 5 |
Netflix
NFLX
|
+$423M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.29% |
| 2 | Technology | 1.9% |
| 3 | Financials | 1.28% |
| 4 | Communication Services | 1.02% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
PUT
Insperity
NSP
$2.01B
| $7.49M | ﹤0.01% |
78,600
+74,900
| +2,024% | +$6.44M |
|
2227
PUT
Caesars Entertainment
CZR
$6.04B
| $7.48M | ﹤0.01% |
191,300
+153,500
| +406% | +$6.35M |
|
2228
Macerich
MAC
$6.85B
| $7.48M | ﹤0.01% |
+131,580
| New | +$7.46M |
|
2229
CALL
LivaNova
LIVN
$4.38B
| $7.48M | ﹤0.01% |
+74,900
| New | +$6.8M |
|
2230
CALL
TG Therapeutics
TGTX
$8.41B
| $7.48M | ﹤0.01% |
568,600
+122,000
| +27% | +$1.68M |
|
|
IFLN
2231
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
| $7.47M | ﹤0.01% |
408,712
+364,050
| +815% | +$6.72M |
|
2232
CALL
Axalta
AXTA
$7.83B
| $7.47M | ﹤0.01% |
246,500
-88,200
| -26% | -$2.77M |
|
|
ONC
2233
CALL
BeOne Medicines Ltd
ONC
$42.2B
| $7.46M | ﹤0.01% |
48,500
-85,900
| -64% | -$15.3M |
|
2234
CALL
IQVIA
IQV
$43.4B
| $7.45M | ﹤0.01% |
74,600
+11,300
| +18% | +$1.13M |
|
2235
CALL
Invesco CurrencyShares British Pound Sterling Trust
FXB
$65.3M
| $7.44M | ﹤0.01% |
58,100
-73,000
| -56% | -$9.64M |
|
|
PE
2236
CALL
DELISTED
PARSLEY ENERGY INC
PE
| $7.44M | ﹤0.01% |
245,700
-186,600
| -43% | -$5.5M |
|
2237
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.65B
| $7.44M | ﹤0.01% |
128,560
+89,292
| +227% | +$5.43M |
|
|
WCG
2238
CALL
DELISTED
Wellcare Health Plans, Inc.
WCG
| $7.44M | ﹤0.01% |
30,200
-18,500
| -38% | -$4.03M |
|
2239
iShares Core S&P 500 ETF
IVV
$901B
| $7.43M | ﹤0.01% |
+27,210
| New | +$7.4M |
|
2240
PUT
ICU Medical
ICUI
$4.43B
| $7.43M | ﹤0.01% |
25,300
+15,600
| +161% | +$4.26M |
|
|
NFX
2241
CALL
DELISTED
Newfield Exploration
NFX
| $7.42M | ﹤0.01% |
245,400
-40,500
| -14% | -$1.14M |
|
2242
PUT
Jazz Pharmaceuticals
JAZZ
$16.2B
| $7.41M | ﹤0.01% |
43,000
-71,000
| -62% | -$11.6M |
|
2243
PUT
Dine Brands
DIN
$423M
| $7.4M | ﹤0.01% |
98,900
-138,800
| -58% | -$10M |
|
|
AMJ
2244
CALL
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $7.39M | ﹤0.01% |
277,900
-53,700
| -16% | -$1.41M |
|
|
MZOR
2245
CALL
DELISTED
Mazor Robotics Ltd.
MZOR
| $7.38M | ﹤0.01% |
133,000
+41,100
| +45% | +$2.38M |
|
2246
CALL
Century Communities
CCS
$1.97B
| $7.38M | ﹤0.01% |
233,900
-84,400
| -27% | -$2.59M |
|
|
ARNA
2247
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $7.37M | ﹤0.01% |
169,054
-44,979
| -21% | -$1.93M |
|
2248
Markel Group
MKL
$22.5B
| $7.37M | ﹤0.01% |
+6,797
| New | +$7.68M |
|
2249
PUT
Columbia Financial
CLBK
$1.21B
| $7.37M | ﹤0.01% |
+445,000
| New | +$7.4M |
|
2250
PUT
Red Robin
RRGB
$180M
| $7.36M | ﹤0.01% |
158,000
+92,800
| +142% | +$5.26M |
|
Similar funds
Jeff Yass's Q2 2018 Portfolio in Review
As of Q2 2018, Jeff Yass held 11,136 positions worth $291B, up 3.8% from $281B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2018 filing shows 1,911 new, 3,840 increased, 3,666 reduced and 1,619 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M. The largest sale was Meta Platforms (Facebook), an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q2 2018 buy was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $696M increase.
- Jeff Yass's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $1.5B.
- Jeff Yass fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2018, selling an estimated $341M.
- Jeff Yass's ten largest holdings make up 26% of its $291B portfolio in Q2 2018.
- Jeff Yass opened 1,911 new positions and closed 1,619 in Q2 2018.
- Jeff Yass's portfolio value rose 3.8% quarter-over-quarter to $291B.
Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.